Oocyte Retrieval Needles Market
Oocyte Retrieval Needles Market Overview 2025 to 2035
The oocyte retrieval needles market is experiencing a surge in demand, driven by the rising adoption of assisted reproductive technology (ART) and advancements in fertility treatments. Between 2025 and 2035, the market is projected to grow at a CAGR of 8.3%, reaching USD 825.6 million by 2035, up from USD 460.1 million in 2025.
| Attributes |
Key Statistics |
|---|---|
|
Expected Base Year Value (2025) |
USD 460.1 million |
|
Anticipated Forecast Value (2035) |
USD 825.6 million |
|
Estimated Growth (2025-2035) |
8.3% CAGR |
Market Growth Drivers
- Rising Prevalence of Infertility – Global infertility rates are increasing, boosting demand for in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) procedures.
- Technological Advancements – Innovations in ultrasound-guided retrieval needles, minimally invasive techniques, and single-use disposable designs improve safety and efficiency.
- Growing Awareness & Acceptance of ART – Increased awareness and social acceptance of fertility treatments drive market expansion.
- Government Support & Insurance Coverage – Several countries are implementing policies to support infertility treatments, increasing accessibility.
- Increasing Number of Fertility Clinics – The global expansion of ART centers and fertility clinics is contributing to the adoption of advanced oocyte retrieval technologies.
Market Segmentation
By Product Type
| Product Type |
Market Share (2025) |
|---|---|
|
Single Lumen Needle |
55% |
|
Double Lumen Needle |
45% |
By End-User
| End-User |
Market Share (2025) |
|---|---|
|
Hospitals & Surgical Centers |
40% |
|
Fertility Clinics |
50% |
|
Research Institutes |
10% |
Geographical Insights
| Country |
CAGR (2025-2035) |
|---|---|
|
United States |
8.8% |
|
United Kingdom |
9.2% |
|
China |
8.6% |
|
Japan |
8.3% |
|
South Korea |
7.9% |
- North America: Leading market with high ART adoption rates and strong healthcare infrastructure.
- Europe: Government support and affordable fertility treatments contribute to steady growth.
- Asia-Pacific: Expanding fertility clinics and increasing infertility rates drive demand in the region.
Challenges & Restraints
- High Cost of ART Procedures – Infertility treatments can be expensive, limiting accessibility.
- Lack of Standardized Protocols – Variations in needle design, stimulation regimens, and retrieval techniques create inconsistencies.
- Limited Skilled Professionals – The need for highly trained reproductive endocrinologists and embryologists restricts market growth.
- Competition from Alternative Fertility Solutions – Non-invasive treatments and alternative ART methods pose challenges.
Competitive Landscape & Key Players
The oocyte retrieval needles market is dominated by key industry players investing in product innovation, strategic collaborations, and global expansion. Leading companies include:
- Vitrolife
- Rocket Medical
- RI.MOS.
- Gynetics Medical Products
- Kitazato Corporation
- Wallace™ (A CooperSurgical Company)
- Gynemed Medizinprodukte GmbH & Co. KG
- Biolife Italiana S.r.l.
Recent Developments
- January 2025 – CooperSurgical launched next-generation oocyte retrieval needles with enhanced safety features.
- September 2024 – Vitrolife expanded its product portfolio with single-use sterile retrieval needles.
- June 2024 – Rocket Medical introduced ultrasound-guided micro-needle designs for minimally invasive egg retrieval.
Frequently Asked Questions (FAQs)
Q1: What is the projected market size of oocyte retrieval needles in 2025?
A: The market is expected to reach USD 460.1 million in 2025.
Q2: How fast is the oocyte retrieval needles market growing?
A: The market is expanding at a CAGR of 8.3% from 2025 to 2035.
Q3: Which companies dominate the oocyte retrieval needles market?
A: Key players include Vitrolife, Rocket Medical, RI.MOS., and Kitazato Corporation.
Conclusion & Call to Action
The oocyte retrieval needles market is on an upward trajectory, driven by advancements in ART, rising infertility rates, and increasing global adoption of fertility treatments. Companies investing in ultrasound-guided technologies, minimally invasive procedures, and single-use safety designs are positioned for sustained market leadership.
Take action now! Contact us today to access the full report and propel your business forward.